GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)

NSE:GLAXO Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	456,930	386,822	487,432	329,173	224,319	281,714
Market Cap Growth	4.12%	-20.64%	48.08%	46.74%	-20.37%	15.45%
Enterprise Value	435,137	366,569	466,472	313,334	211,499	270,099
Last Close Price	2710.00	2226.33	2772.70	1842.29	1225.87	1452.77

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	39.74	37.34	52.55	55.80	36.73	16.62
PS Ratio	11.04	10.12	13.00	9.53	6.90	8.59
PB Ratio	24.41	17.06	24.98	18.52	12.88	10.58
P/TBV Ratio	24.49	17.11	25.15	18.77	13.14	10.72
P/FCF Ratio	47.54	45.62	38.48	59.76	50.96	36.30
P/OCF Ratio	44.54	42.82	37.79	56.56	46.33	34.75

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	10.52	9.59	12.44	9.07	6.50	8.24
EV/EBITDA Ratio	30.85	28.50	40.47	35.58	26.83	36.36
EV/EBIT Ratio	32.16	29.38	41.86	37.35	28.26	38.65
EV/FCF Ratio	45.28	43.23	36.82	56.89	48.05	34.80

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.02	0.02	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	0.03	0.03	0.01	0.02	0.02	0.03
Debt / FCF Ratio	0.04	0.04	0.01	0.03	0.04	0.03
Net Debt / Equity Ratio	-1.16	-1.20	-1.27	-1.03	-0.94	-1.06
Net Debt / EBITDA Ratio	-1.56	-2.12	-2.16	-2.09	-2.08	-3.78
Net Debt / FCF Ratio	-2.26	-3.21	-1.96	-3.34	-3.72	-3.62
Asset Turnover	1.09	0.91	0.98	1.00	0.82	0.85
Inventory Turnover	2.76	2.93	2.81	2.75	2.62	2.55
Quick Ratio	1.42	1.72	1.50	1.45	1.50	1.83
Current Ratio	1.79	2.03	1.79	1.84	1.88	2.18
Return on Equity (ROE)	63.90%	49.11%	49.75%	33.53%	27.59%	18.39%
Return on Assets (ROA)	22.27%	18.50%	18.17%	15.24%	11.75%	11.28%
Return on Invested Capital (ROIC)	-	-	-	-	529.48%	-
Return on Capital Employed (ROCE)	62.90%	49.00%	50.60%	41.30%	37.40%	23.80%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	2.52%	2.68%	1.90%	1.79%	2.72%	6.02%
FCF Yield	2.10%	2.19%	2.60%	1.67%	1.96%	2.76%
Dividend Yield	2.11%	2.50%	1.46%	1.65%	2.42%	1.80%
Payout Ratio	84.59%	68.92%	80.79%	91.80%	249.80%	29.89%
Total Shareholder Return	2.35%	2.50%	1.46%	1.65%	2.42%	1.80%

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error